Duchenne Care UK orthopaedic guideline recognised by NICE

We are pleased to share that NICE has recognised another clinical guideline published as part of the Duchenne Care UK national programme that we fund. NICE (the National Institute for Health and Care Excellence) has reviewed Duchenne Care UK’s recommendations on...
Duchenne Care UK launches psychosocial guidelines

Duchenne Care UK launches psychosocial guidelines

We are delighted to share that psychosocial guidelines for Duchenne muscular dystrophy have been published by Duchenne Care UK. We are proud to be a key funder of the psychosocial programme, which is part of a wider, multi‑year national effort by Duchenne Care UK to...
Duchenne Care UK launches psychosocial guidelines

Duchenne Care UK strives for best care for all at national meeting

The pychosocial working group gathered around Duchenne Care UK’s newly published education guidelines for teachers. Pictured from left: Duchenne Care UK project coordinator Adam Kerr; Pathfinders advocacy officer Sam Cornelius-Light; consultant child and...

DMD Care UK respiratory guideline recognised by NICE

The Duchenne Research Fund is delighted to share that NICE has recognised the respiratory care guidelines that were created and published by the DMD Care UK programme that we fund. This follows NICE’s recognition of DMD Care UK’s cardiac guidelines in...

DMD Care UK publishes annual meeting report

DMD Care UK has published a report following its national meeting earlier this year, sharing insights into the success of its workshops and knowledge sharing. More than 80 clinical professionals attended in person, and there were more than 170 dial-ins to online...
DMD Care UK national meeting drives improved care

DMD Care UK national meeting drives improved care

Pictured: DRF director of operations Sheli Rodney (second from right) with fellow members of the Psychosocial Working Group: disability and education specialist Dr Janet Hoskin, DMD Care UK manager Cathy Turner, Pathfinders Neuromuscular Alliance trustee Benjamin...

NICE approves DRF-funded treatment for Duchenne

New medicine for Duchenne muscular dystrophy, funded by Duchenne Research Fund and patient groups, becomes first approved treatment in the UK for all patients with Duchenne The National Institute for Health and Care Excellence (NICE) has approved vamorolone for use on...

John Walton Muscular Dystrophy Research Centre marks 10 years

We were invited to join the celebrations for the John Walton Muscular Dystrophy Research Centre’s 10th anniversary in Newcastle. The late Lord John Walton was a pioneering neurologist who made an enormous impact on muscular dystrophy diagnosis and treatment. The...

Solid begins dosing next-generation gene therapy

We are pleased to share that Solid Biosciences has begun dosing patients in the Phase I/II clinical study of its next-generation gene therapy, SGT-003. The study, INSPIRE DUCHENNE, is ongoing at two sites in the US – Nationwide Children’s Hospital in Columbus, Ohio,...

DMD Care UK explores next steps for patient care

On 29th February, Rare Disease Day, we were pleased to be part of the 2024 national meeting for DMD Care UK. More than 130 clinicians and 25 patient representatives are now involved in DMD Care UK, giving their time and expertise across no fewer than 13 working groups...